| 2017 |
CCPG1 is an ER-resident transmembrane protein that functions as a non-canonical autophagy cargo receptor for ER-phagy (reticulophagy). It directly binds to ATG8-family proteins (LC3, GABARAP) via an LIR motif, and independently and via a discrete motif binds to FIP200/RB1CC1. Both interactions are required for its function as a reticulophagy receptor. CCPG1 transcription is induced by the unfolded protein response, directly linking ER stress to ER-phagy. In vivo, CCPG1 loss causes ER luminal protein aggregation, UPR hyperactivation, and exocrine pancreas tissue injury. |
Co-immunoprecipitation, motif mutagenesis, in vivo mouse knockout with histological and biochemical readouts, UPR reporter assays |
Developmental Cell |
High |
29290589 29916296 30263939
|
| 2006 |
CCPG1 (originally identified as a scaffold protein) binds to the DH/PH domain tandem of the RhoGEF Dbs and inhibits Dbs exchange activity toward RhoA but not Cdc42, thereby restricting substrate utilization of this promiscuous RhoGEF. The isolated Dbs-binding domain of CCPG1 was not sufficient to suppress RhoA exchange activity, indicating a regulatory (not merely tethering) interaction. CCPG1 also recruits endogenous Src kinase into Dbs-containing complexes and interacts with Cdc42. |
Co-immunoprecipitation, GEF activity assays in mammalian cells, siRNA knockdown of endogenous CCPG1, domain truncation experiments |
Molecular and Cellular Biology |
Medium |
17000758
|
| 2023 |
The ER luminal region of CCPG1 contains several highly conserved cargo-interacting regions (CIRs) that directly interact with specific ER luminal cargo proteins for ER-phagy. The aggregation-prone 6xIAPP and the endogenous cargo P3H4 bind to different CIRs, establishing CCPG1 as a bispecific ER-phagy receptor that bridges ER luminal cargo recognition with the autophagosomal membrane machinery. |
In vitro binding assays, pulldown experiments with truncation/deletion mutants of CCPG1 luminal region, cell-based degradation assays with 6xIAPP and P3H4 as substrates |
Molecular Biology of the Cell |
High |
36735498 40395301
|
| 2023 |
In granulosa cells, ER stress activates reticulophagy through an ATF4–MAP1LC3A–CCPG1 pathway. ATF4 transcriptionally targets MAP1LC3A, and MAP1LC3A physically interacts with CCPG1 (demonstrated by Co-IP). CCPG1 knockdown shifts granulosa cell death from apoptosis to necroptosis mediated via STAT1/STAT3-(p)RIPK1-(p)RIPK3-(p)MLKL, impairing ER proteostasis. |
RNAi knockdown of ATF4 and CCPG1, ChIP-seq (ATF4 at MAP1LC3A promoter), co-immunoprecipitation (MAP1LC3A–CCPG1 interaction), cell death assays |
International Journal of Molecular Sciences |
Medium |
36769070
|
| 2025 |
Cisplatin treatment inhibits reticulophagy by downregulating CCPG1 expression through the ATM–CHEK2/Chk2 signaling pathway in bladder cancer cells. Overexpression of wild-type CCPG1, but not an LC3-binding-deficient variant, rescues reticulophagy and promotes tumor growth, establishing that the LC3-interaction of CCPG1 is functionally required for its pro-tumorigenic reticulophagy activity. |
CCPG1 knockdown and overexpression (wild-type vs. LC3-binding-deficient mutant), pharmacological inhibition of ATM-CHEK2 pathway, reticulophagy flux assays, cell proliferation and apoptosis assays |
Autophagy |
Medium |
41361995
|
| 2025 |
In KRAS-driven pancreatic oncogenesis, ER-phagy failure causes pathologic aggregation of a subset of ER luminal proteins, including REG3B, due to failure to physically interact with the ER-phagy receptor CCPG1. Engineered REG3B mutants that cannot bind CCPG1 and form aggregates are sufficient to drive acinar-ductal metaplasia-primed epithelial cell states, placing CCPG1 upstream of proteostatic control of pre-malignant transformation. |
Proteomics, high-resolution imaging, spatial transcriptomics, genetically engineered CCPG1-deficient mice, REG3B interaction mutants |
bioRxiv (preprint)preprint |
Medium |
|
| 2025 |
The pathogenic R519Q GluN2B NMDAR variant retained in the ER is recognized by the ER-phagy receptor CCPG1 (along with RTN3L) for autophagic clearance via the lysosomal pathway. |
Pharmacological and genetic autophagy inhibition, LIR-motif disruption of GluN2B, co-localization and interaction assays with CCPG1 and RTN3L |
bioRxiv (preprint)preprint |
Low |
|